Vivos Inc. Announces Certification of Three New IsoPet® Precision Radionuclide Therapy Regional Clinics

August 7, 2023

Richland WA, Aug. 07, 2023 (GLOBE NEWSWIRE) — Vivos Inc. (OTCQB:RDGL), Vivos Inc is pleased to announce that it certified three additional clinics to offer Isopet^® Precision Radionuclide Therapy (PRT).

Related news for (RDGL)

Vivos Inc. Certifies University of Florida Veterinary Hospital for IsoPet® Precision Radionuclide Therapy™
Vivos Inc. Achieves Record Growth in IsoPet® Animal Cancer Treatments in Q1 2025
Vivos Inc. Reports Encouraging Human Clinical Trial Results and Announces Expansion Plans
Vivos Inc.’s IsoPet® Division Achieves Exceptional Growth in 2024, Expanding Certified Veterinary Clinics Nationwide
Vivos Inc. Announces Launch of Groundbreaking RadioGel® Precision Radionuclide Therapy™ Human Clinical Trial

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.

Vivos Inc. Announces Certification of Three New IsoPet® Precision Radionuclide Therapy Regional Clinics

Related news for (RDGL)

Follow Us on Social Media

Sign Up for Our Newsletter

Related news for (RDGL)

Friday the 14th Follow-Up: $14 Fever Sweeps the Street

Wall Street’s AI and Infrastructure Trio Set the Tone

Next Entertainment Boom Ignited, Blowout Earnings, Bio Science, and Merger News, as Wall Street Turns Up the Volume

VENU Ignites America’s Next Entertainment Boom

Follow Us on Social Media

Sign Up for Our Newsletter